-
NMPA Announcement on Revising the Package Inserts of 14 Drug Varieties Including Paracetamol, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
2021-04-21
In order to further protect the medication safety for the public, NMPA decided to revise the package inserts of 14 drug varieties.
-
NMPA Announcement on Issuing 5 Technical Review Guidances for Registration
2021-04-15
To strengthen the supervision and guidance of medical device registration and further improve the quality of registration review, NMPA has organized to formulate the following guidances, which were issued on April 7.
-
NMPA Announcement on Issuing the Principles for the Classification Defining of Recombinant Collagen Products
2021-04-13
NMPA has organized to formulate the Principles for the Classification Defining of Recombinant Collagen Products, which was issued on April 13.
-
NMPA Announcement on Issuing the Standard for the Evaluation of Efficacy Claims of Cosmetics
2021-04-09
The NMPA has organized to formulate the Standard for the Evaluation of Efficacy Claims of Cosmetics, which was issued on April 8 and shall take effect as of May 1, 2021.
-
NMPA Announcement on Issuing the Classification Rules and Classification Catalogue of Cosmetics
2021-04-09
The NMPA has formulated the Classification Rules and Classification Catalogue of Cosmetics, which was issued on April 8 and shall take effect as of May 1, 2021.
-
NMPA Announcement on Issues about Implementing the Rules for Registration and Notification Dossiers of Cosmetics
2021-03-05
In order to implement the Regulations for the Supervision and Administration of Cosmetics and the Provisions for Registration and Notification of Cosmetics and further standardize the administration on registration and notification of cosmetics, the issues about implementing the Rules for the Registration and Notification Dossiers of Cosmetics is hereby announced as follows.